---
title: "Innovita Biological Technology Co., Ltd. (688253.SH)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/688253.SH.md"
symbol: "688253.SH"
name: "Innovita Biological Technology Co., Ltd."
industry: "Health Care Supplies"
---

# Innovita Biological Technology Co., Ltd. (688253.SH)

| Item | Detail |
|------|--------|
| Industry | Health Care Supplies |
| Location | CN Market |
| Website | [www.innovita.com.cn](https://www.innovita.com.cn) |

## Company Profile

Innovita Biological Technology Co., Ltd., a biopharmaceutical enterprise, engages in the research and development, production and sales of POCT rapid diagnostic products. It offers covid-19 test, respiratory disease test, gastrointestinal disease test, fertility test, tropical disease test, and hepa...

## Financial Score

> *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.*
> Updated: 2026-02-17T04:30:07.000Z

**Overall: C (0.54)**

**Industry**: Health Care Supplies

| Metric | Value |
|--------|-------|
| Industry Ranking | 25 / 41 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

### Score Analysis

**Style Score**: 

#### Growth Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -40.18% |  |
| Net Profit YoY | -59.81% |  |

#### Value Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| P/B Ratio | 2.36 |  |
| Dividend Ratio | 1.57% |  |


**Size Score**: 

#### Market Cap Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 4.79B |  |

#### Revenue Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue | 430.98M |  |


**Multi Score**: C

#### Profit Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 6.55% | C |
| Profit Margin | 30.96% | A |
| Gross Margin | 72.96% | A |

#### Growth Score: E

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -40.18% | E |
| Net Profit YoY | -59.81% | D |
| Total Assets YoY | -0.63% | D |
| Net Assets YoY | -0.56% | D |

#### Cash Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| Cash Flow Margin | 322.96% | C |
| OCF YoY | -40.18% | E |

#### Operating Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| Turnover | 0.20 | D |

#### Debt Score: A

| Indicator | Value | Rating |
|-----------|-------|--------|
| Gearing Ratio | 5.76% | A |


```chart-data:radar
{
  "title": "Longbridge Financial Score - Innovita Biological Technology Co., Ltd.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Profit",
      "grade": "B",
      "indicators": [
        {
          "name": "ROE",
          "value": "6.55%",
          "rating": "C"
        },
        {
          "name": "Profit Margin",
          "value": "30.96%",
          "rating": "A"
        },
        {
          "name": "Gross Margin",
          "value": "72.96%",
          "rating": "A"
        }
      ]
    },
    {
      "name": "Growth",
      "grade": "E",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "-40.18%",
          "rating": "E"
        },
        {
          "name": "Net Profit YoY",
          "value": "-59.81%",
          "rating": "D"
        },
        {
          "name": "Total Assets YoY",
          "value": "-0.63%",
          "rating": "D"
        },
        {
          "name": "Net Assets YoY",
          "value": "-0.56%",
          "rating": "D"
        }
      ]
    },
    {
      "name": "Cash",
      "grade": "D",
      "indicators": [
        {
          "name": "Cash Flow Margin",
          "value": "322.96%",
          "rating": "C"
        },
        {
          "name": "OCF YoY",
          "value": "-40.18%",
          "rating": "E"
        }
      ]
    },
    {
      "name": "Operating",
      "grade": "D",
      "indicators": [
        {
          "name": "Turnover",
          "value": "0.20",
          "rating": "D"
        }
      ]
    },
    {
      "name": "Security",
      "grade": "A",
      "indicators": [
        {
          "name": "Gearing Ratio",
          "value": "5.76%",
          "rating": "A"
        }
      ]
    }
  ]
}
```

### Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
|------|------|--------|--------|-----------|----------|------|--------|
| 01 | Snibe (SZ.300832) | A | C | C | A | C | B |
| 02 | Winner Medical (SZ.300888) | B | A | B | B | B | B |
| 03 | MTM (SH.688029) | A | B | B | A | B | B |
| 04 | Eyebright Medical (SH.688050) | A | B | C | B | C | B |
| 05 | Sansure Biotech (SH.688289) | B | B | D | B | B | B |

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 35.88 | 17/41 | 32.82 | 23.31 | 21.07 |
| PB | 2.36 | 21/41 | 2.31 | 2.16 | 2.08 |
| PS (TTM) | 11.11 | 31/41 | 10.16 | 8.36 | 7.55 |
| Dividend Yield | 1.57% | 19/41 | 1.78% | 1.65% | 1.23% |

## Institutional View

### Analyst Rating Distribution

> As of 2025-11-12T16:00:00.000Z

Total Analysts: **1**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 1 | 100% |
| Overweight | 0 | 0% |
| Hold | 0 | 0% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 34.95 |
| Highest Target | 37.68 |
| Lowest Target | 37.68 |

## References

- [Company Overview](https://longbridge.com/en/quote/688253.SH/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/688253.SH/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/688253.SH/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.